Straumann Holding AG Total Long-Term Assets 2012-2021 | SAUHY

Straumann Holding AG total long-term assets from 2012 to 2021. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Straumann Holding AG total long-term assets for the quarter ending December 31, 2021 were $1.772B, a 20.56% increase year-over-year.
  • Straumann Holding AG total long-term assets for 2021 were $1.575B, a 5.74% increase from 2020.
  • Straumann Holding AG total long-term assets for 2020 were $1.489B, a 1.89% decline from 2019.
  • Straumann Holding AG total long-term assets for 2019 were $1.518B, a 35.04% increase from 2018.
Straumann Holding AG Annual Total Long-Term Assets
(Millions of US $)
2021 $1,575
2020 $1,489
2019 $1,518
2018 $1,124
2017 $1,010
2016 $642
2015 $521
2014 $545
2013 $494
2012 $486
2011 $289
Straumann Holding AG Quarterly Total Long-Term Assets
(Millions of US $)
2021-12-31 $1,772
2020-12-31 $1,648
2020-06-30 $738
2019-12-31 $1,624
2018-12-31 $1,470
2017-12-31 $1,332
2017-06-30 $551
2016-12-31 $521
2016-06-30 $503
2015-12-31 $805
2014-12-31 $827
2013-12-31 $404
2013-06-30 $373
2012-12-31 $486
2012-06-30 $418
2011-12-31 $164
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.738B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.498B 20.60
Becton Dickinson (BDX) United States $71.806B 18.82
Cardinal Health (CAH) United States $29.872B 16.00
West Pharmaceutical Services (WST) United States $24.736B 50.53
Labcorp (LH) United States $20.893B 17.32
Cooper (COO) United States $19.270B 26.09
Align Technology (ALGN) United States $16.357B 31.30
Henry Schein (HSIC) United States $9.975B 19.00
Merit Medical Systems (MMSI) United States $6.345B 32.40
DENTSPLY SIRONA (XRAY) United States $3.928B 10.68
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.217B 18.50
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.265B 35.27
Pro-Dex (PDEX) United States $0.124B 18.89